Evidence map›Paper›PMID 29186347›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Severe Respiratory Illness Associated With Rhinovirus During the Enterovirus D68 Outbreak in the United States, August 2014-November 2014.

Mila M Prill, Rebecca M Dahl, Claire M Midgley, Shur-Wern Wang Chern, Xiaoyan Lu, Daniel R Feikin, Senthilkumar K Sakthivel, W Allan Nix, John T Watson, Susan I Gerber and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Enhanced Neutralizing Antibody Responses to Rhinovirus C and Age-Dependent Patterns of Infection.American journal of respiratory and critical care medicine · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Mila M PrillDivision of Viral Diseases, Centers for Disease Control and Prevention Atlanta, Georgia.
Rebecca M DahlMAXIMUS Federal, contracting agency to the Division of Viral Diseases, Centers for Disease Control and Prevention Atlanta, Georgia.
Claire M MidgleyDivision of Viral Diseases, Centers for Disease Control and Prevention Atlanta, Georgia.
Shur-Wern Wang ChernDivision of Viral Diseases, Centers for Disease Control and Prevention Atlanta, Georgia.
Xiaoyan LuDivision of Viral Diseases, Centers for Disease Control and Prevention Atlanta, Georgia.
Daniel R FeikinDivision of Viral Diseases, Centers for Disease Control and Prevention Atlanta, Georgia.
Senthilkumar K SakthivelBattelle, Columbus, Ohio.
W Allan NixDivision of Viral Diseases, Centers for Disease Control and Prevention Atlanta, Georgia.
John T WatsonDivision of Viral Diseases, Centers for Disease Control and Prevention Atlanta, Georgia.
Susan I GerberDivision of Viral Diseases, Centers for Disease Control and Prevention Atlanta, Georgia.
M Steven ObersteDivision of Viral Diseases, Centers for Disease Control and Prevention Atlanta, Georgia.
Centers for Disease Control and Prevention · USBattelle · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Background: In 2014, a nationwide outbreak of severe respiratory illness occurred in the United States, primarily associated with enterovirus D68 (EV-D68). A proportion of illness was associated with rhinoviruses (RVs) and other enteroviruses (EVs), which we aimed to characterize further. Methods: Respiratory specimens from pediatric and adult patients with respiratory illness were submitted to the Centers for Disease Control and Prevention during August 2014-November 2014. While initial laboratory testing focused on identification of EV-D68, the negative specimens were typed by molecular sequencing to identify additional EV and RV types. Testing for other pathogens was not conducted. We compared available clinical and epidemiologic characteristics among patients with EV-D68 and RV species A-C identified. Results: Among 2629 typed specimens, 1012 were EV-D68 (39%) and 81 (3.1%) represented 24 other EV types; 968 were RVs (37%) covering 114 types and grouped into 3 human RV species (RV-A, 446; RV-B, 133; RV-C, 389); and 568 (22%) had no RV or EV detected. EV-D68 was more frequently identified in patients who presented earlier in the investigation period. Among patients with EV-D68, RV-A, RV-B, or RV-C, the age distributions markedly differed. Clinical syndromes and intensive care unit admissions by age were largely similar. Conclusions: RVs were commonly associated with severe respiratory illness during a nationwide outbreak of EV-D68, and most clinical. Characteristics were similar between groups. A better understanding of the epidemiology of RVs and EVs is needed to help inform development and use of diagnostic tests, therapeutics, and preventive measures.

Indexed as

Enterovirus D, HumanRhinovirusAdolescentAdultAgedAged, 80 and overBiomarkersChildChild, PreschoolCoinfectionEnterovirus InfectionsFemaleHumansInfantMaleMiddle AgedBiomarkers

Identifiers

PMID29186347
PMCPMC11305614
OpenAlexW2770805267

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.